Skip to main content
. 2023 Jul 24;29(8):1947–1953. doi: 10.1038/s41591-023-02455-9

Fig. 2. Participant screening flowchart.

Fig. 2

This figure summarizes the number of participants captured and retained through the screening process. COMP360, psilocybin.

Source data